Lakeside Q3 FY2025 revenue falls 15% to $3.8M; net loss of $1.07M vs prior profit

Lakeside Holding Ltd

2025-Q3 EPS reported -$0.58 revenue$715,362

Total revenue $3.80M, down from $4.46M YoY; cross-border freight fell 26%, pharma distribution added $0.50M.
Net loss attributable to Lakeside $1.07M ($0.14 per share) vs net income $0.01M in Q3 FY2024.
Nine-month net loss $4.35M ($0.58 per share) vs $0.23M loss a year ago; operating expenses rose to $5.60M from $2.90M.
Hupan Pharma acquisition closed Nov 2024; contributed $715K to nine-month revenue. Convertible debt up to $4.5M secured March 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.